奧比中光(688322.SH):已自主研發深度引擎計算芯片、iToF和dToF感光芯片、結構光專用感光芯片等多類型芯片
格隆匯12月16日丨奧比中光(688322.SH)在投資者互動平台表示,公司致力於打造機器人與AI視覺產業中台,在多個領域內有深度學習算法相關的研究和技術佈局,並且具備數字及模擬芯片的研發實力。在深度學習算法領域,公司具體包括安防及泛娛樂領域的人臉識別、活體檢測、骨架識別、動作捕捉等;機器人感知層面的目標檢測、語義分割及空間感知等;大模型場景下的機械臂大模型、RAG等。在芯片領域,公司目前已自主研發深度引擎計算芯片、iToF和dToF感光芯片、結構光專用感光芯片等多類型芯片。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.